SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001535264-18-000014
Filing Date
2018-02-13
Accepted
2018-02-13 14:14:09
Documents
1
Group Members
ADAM STETTNERAUSTIN MARXEAWM INVESTMENT CO INCDAVID GREENHOUSEMGP ADVISERS LIMITED PARTNERSHIPSPECIAL SITUATIONS CAYMAN FUND LPSPECIAL SITUATIONS FUND III QP LPSSCAYMAN LLC

Document Format Files

Seq Description Document Type Size
1 ESSA PHARM 13G/A essa13gt1.txt SC 13G/A 7479
  Complete submission text file 0001535264-18-000014.txt   9307
Mailing Address 527 MADISON AVENUE SUITE 2600 NEW YORK NY 10022
Business Address 527 MADISON AVENUE SUITE 2600 NEW YORK NY 10022 212-319-6670
AWM Investment Company, Inc. (Filed by) CIK: 0001535264 (see all company filings)

IRS No.: 113086452 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5
Business Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 (778) 331-0962
ESSA Pharma Inc. (Subject) CIK: 0001633932 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: SC 13G/A | Act: 34 | File No.: 005-88939 | Film No.: 18602143
SIC: 2834 Pharmaceutical Preparations